Index of /wp-content/uploads/2019/12
Name Last modified Size Description
![[PARENTDIR]](/__ovh_icons/back.gif)
Parent Directory -
![[IMG]](/__ovh_icons/image2.gif)
wsi-imageoptim-banne..> 2019-12-23 13:56 674
wsi-imageoptim-bioge..> 2019-12-22 15:46 787
wsi-imageoptim-merck..> 2019-12-22 15:46 848
wsi-imageoptim-novar..> 2019-12-22 15:46 913
banner_partners-66x6..> 2020-03-11 11:59 925
wsi-imageoptim-banne..> 2020-03-11 12:00 925
Design-sans-titre-37..> 2025-05-02 00:03 937
wsi-imageoptim-celge..> 2019-12-22 15:46 1.0K
Methodology_NEW_V5_E..> 2025-05-01 11:54 1.1K
biogen-66x66.jpg 2020-03-11 11:59 1.1K
wsi-imageoptim-bioge..> 2020-03-11 12:00 1.1K
PolicyAssessmentTool..> 2025-05-01 11:54 1.3K
PolicyAssessmentTool..> 2025-05-01 11:54 1.3K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 1.3K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 1.3K
founders-66x66.jpg 2025-05-01 11:54 1.3K
wsi-imageoptim-found..> 2025-05-01 11:54 1.3K
novartis-66x66.jpg 2020-03-11 11:59 1.3K
wsi-imageoptim-novar..> 2020-03-11 12:00 1.3K
RETHINKING_MS_Europe..> 2025-05-01 11:54 1.3K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 1.3K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 1.3K
merck-66x66.jpg 2020-03-11 11:59 1.3K
wsi-imageoptim-merck..> 2020-03-11 12:00 1.3K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 1.4K
celgene-66x66.jpg 2020-03-11 11:59 1.6K
wsi-imageoptim-celge..> 2020-03-11 12:00 1.6K
banner_partners-200x..> 2020-03-11 11:59 1.6K
wsi-imageoptim-banne..> 2020-03-11 12:00 1.6K
EBC-Newsletter-Novem..> 2025-05-01 11:54 1.7K
MS-in-times-of-COVID..> 2025-05-01 17:50 1.7K
MS-in-times-of-COVID..> 2025-05-01 17:50 1.7K
MS-in-times-of-COVID..> 2025-05-01 17:33 1.7K
wsi-imageoptim-found..> 2019-12-22 16:04 1.7K
Virtual-exhibition-f..> 2021-11-23 14:37 1.8K
biogen-200x95.jpg 2020-03-11 11:59 2.0K
wsi-imageoptim-bioge..> 2020-03-11 12:00 2.0K
banner_partners-150x..> 2020-03-11 11:59 2.1K
wsi-imageoptim-banne..> 2020-03-11 12:00 2.1K
founders-200x33.jpg 2025-05-01 11:54 2.2K
wsi-imageoptim-found..> 2025-05-01 11:54 2.2K
Methodology_NEW_V5_E..> 2025-05-01 11:54 2.3K
Methodology_NEW_V5_E..> 2025-05-01 11:54 2.5K
banner_partners-177x..> 2020-03-11 11:59 2.5K
wsi-imageoptim-banne..> 2020-03-11 12:00 2.5K
novartis-200x54.jpg 2020-03-11 11:59 2.5K
wsi-imageoptim-novar..> 2020-03-11 12:00 2.5K
banner_partners-300x..> 2020-03-11 11:59 2.5K
wsi-imageoptim-banne..> 2020-03-11 12:00 2.5K
Methodology_NEW_V5_E..> 2025-05-01 11:54 2.7K
founders-150x150.jpg 2025-05-01 11:54 2.7K
wsi-imageoptim-found..> 2025-05-01 11:54 2.7K
merck-200x95.jpg 2020-03-11 11:59 2.8K
wsi-imageoptim-merck..> 2020-03-11 12:00 2.8K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 2.8K
PolicyAssessmentTool..> 2025-05-01 11:54 2.9K
PolicyAssessmentTool..> 2025-05-01 11:54 2.9K
Methodology_NEW_V5_E..> 2025-05-01 11:54 2.9K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 2.9K
merck-150x150.jpg 2020-03-11 11:59 2.9K
wsi-imageoptim-merck..> 2020-03-11 12:00 2.9K
founders-177x142.jpg 2025-05-01 11:54 2.9K
wsi-imageoptim-found..> 2025-05-01 11:54 2.9K
novartis-177x142.jpg 2020-03-11 11:59 3.0K
wsi-imageoptim-novar..> 2020-03-11 12:00 3.0K
novartis-150x150.jpg 2020-03-11 11:59 3.0K
wsi-imageoptim-novar..> 2020-03-11 12:00 3.0K
biogen-150x150.jpg 2020-03-11 11:59 3.0K
wsi-imageoptim-bioge..> 2020-03-11 12:00 3.0K
biogen-177x142.jpg 2020-03-11 11:59 3.1K
wsi-imageoptim-bioge..> 2020-03-11 12:00 3.1K
PolicyAssessmentTool..> 2025-05-01 11:54 3.1K
PolicyAssessmentTool..> 2025-05-01 11:54 3.1K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 3.2K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 3.2K
Design-sans-titre-37..> 2025-05-02 00:03 3.2K
RETHINKING_MS_Europe..> 2025-05-01 11:54 3.2K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 3.2K
biogen-300x143.jpg 2020-03-11 11:59 3.2K
wsi-imageoptim-bioge..> 2020-03-11 12:00 3.2K
Methodology_NEW_V5_E..> 2025-05-01 11:54 3.2K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 3.3K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 3.3K
founders-300x49.jpg 2025-05-01 11:54 3.3K
wsi-imageoptim-found..> 2025-05-01 11:54 3.3K
merck-177x142.jpg 2020-03-11 11:59 3.3K
wsi-imageoptim-merck..> 2020-03-11 12:00 3.3K
Design-sans-titre-37..> 2025-05-02 00:03 3.5K
PolicyAssessmentTool..> 2025-05-01 11:54 3.6K
PolicyAssessmentTool..> 2025-05-01 11:54 3.6K
banner_partners-400x..> 2020-03-11 11:59 3.6K
wsi-imageoptim-banne..> 2020-03-11 12:00 3.6K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 3.6K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 3.6K
RETHINKING_MS_Europe..> 2025-05-01 11:54 3.7K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 3.8K
PolicyAssessmentTool..> 2025-05-01 11:54 3.9K
PolicyAssessmentTool..> 2025-05-01 11:54 3.9K
Design-sans-titre-37..> 2025-05-02 00:03 3.9K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 4.0K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 4.1K
Methodology_NEW_V5_E..> 2025-05-01 11:54 4.1K
novartis-300x81.jpg 2020-03-11 11:59 4.1K
wsi-imageoptim-novar..> 2020-03-11 12:00 4.1K
PolicyAssessmentTool..> 2025-05-01 11:54 4.1K
PolicyAssessmentTool..> 2025-05-01 11:54 4.1K
Design-sans-titre-37..> 2025-05-02 00:03 4.1K
banner_partners-300x..> 2025-05-01 11:53 4.2K
wsi-imageoptim-banne..> 2025-05-01 11:54 4.2K
banner_partners-320x..> 2025-05-01 11:53 4.2K
wsi-imageoptim-banne..> 2025-05-01 11:54 4.2K
Methodology_NEW_V5_E..> 2025-05-01 11:54 4.2K
Methodology_NEW_V5_E..> 2020-03-11 11:59 4.2K
Methodology_NEW_V5_E..> 2025-05-01 11:54 4.3K
MS-in-times-of-COVID..> 2025-05-01 17:50 4.3K
Methodology_NEW_V5_E..> 2019-12-02 22:06 4.3K
Methodology_NEW_V5_E..> 2025-05-01 11:54 4.3K
celgene-150x150.jpg 2020-03-11 11:59 4.4K
wsi-imageoptim-celge..> 2020-03-11 12:00 4.4K
MS-in-times-of-COVID..> 2025-05-01 17:50 4.5K
MS-in-times-of-COVID..> 2025-05-01 17:50 4.5K
RETHINKING_MS_Spain_..> 2020-03-11 12:00 4.6K
celgene-177x142.jpg 2020-03-11 11:59 4.6K
wsi-imageoptim-celge..> 2020-03-11 12:00 4.6K
PolicyAssessmentTool..> 2020-03-11 11:59 4.6K
PolicyAssessmentTool..> 2020-03-11 11:59 4.6K
RETHINKING_MS_in_Ita..> 2020-03-11 12:00 4.7K
merck-300x143.jpg 2025-05-01 11:54 4.7K
wsi-imageoptim-merck..> 2025-05-01 11:54 4.7K
RETHINKING_MS_Spain_..> 2019-12-02 22:06 4.7K
Virtual-exhibition-f..> 2025-05-01 17:50 4.7K
PolicyAssessmentTool..> 2019-12-02 22:06 4.7K
PolicyAssessmentTool..> 2019-12-04 00:19 4.7K
biogen-400x190.jpg 2025-05-01 11:53 4.7K
wsi-imageoptim-bioge..> 2025-05-01 11:54 4.7K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 4.7K
RETHINKING_MS_in_Ita..> 2019-12-02 22:06 4.7K
MS-in-times-of-COVID..> 2025-05-01 17:50 4.7K
MS-in-times-of-COVID..> 2025-05-01 17:50 4.8K
founders-400x65.jpg 2025-05-01 11:54 4.8K
wsi-imageoptim-found..> 2025-05-01 11:54 4.8K
MS-in-times-of-COVID..> 2025-05-01 17:50 4.8K
EBC-Newsletter-Novem..> 2025-05-01 11:54 4.8K
RETHINKING_MS_Denmar..> 2020-03-11 11:59 4.8K
RETHINKING_MS_Europe..> 2020-03-11 12:00 4.8K
ROMANIA_DEF_EBC_pp_0..> 2020-03-11 12:00 4.9K
ROMANIA_DEF_EBC_pp_0..> 2020-03-11 12:00 4.9K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 4.9K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 4.9K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 4.9K
PolicyAssessmentTool..> 2025-05-01 11:54 4.9K
PolicyAssessmentTool..> 2025-05-01 11:54 4.9K
Virtual-exhibition-f..> 2025-05-01 17:50 4.9K
RETHINKING_MS_Denmar..> 2019-12-02 22:06 4.9K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 4.9K
RETHINKING_MS_Europe..> 2019-12-02 22:06 4.9K
ROMANIA_DEF_EBC_pp_0..> 2019-12-02 22:07 5.0K
ROMANIA_DEF_EBC_pp_0..> 2019-12-04 00:19 5.0K
biogen-320x202.jpg 2025-05-01 11:53 5.0K
wsi-imageoptim-bioge..> 2025-05-01 11:54 5.0K
MS-in-times-of-COVID..> 2025-05-01 17:33 5.0K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 5.0K
founders-300x160.jpg 2025-05-01 11:54 5.0K
wsi-imageoptim-found..> 2025-05-01 11:54 5.0K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 5.1K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 5.1K
EBC-Newsletter-Novem..> 2025-05-01 11:54 5.1K
PolicyAssessmentTool..> 2025-05-01 11:54 5.2K
PolicyAssessmentTool..> 2025-05-01 11:54 5.2K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 5.2K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 5.2K
founders-320x160.jpg 2025-05-01 11:54 5.3K
wsi-imageoptim-found..> 2025-05-01 11:54 5.3K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 5.3K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 5.3K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 5.3K
biogen-300x214.jpg 2025-05-01 11:53 5.3K
wsi-imageoptim-bioge..> 2025-05-01 11:54 5.3K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 5.3K
celgene-200x167.jpg 2025-05-01 11:53 5.4K
wsi-imageoptim-celge..> 2025-05-01 11:54 5.4K
Virtual-exhibition-f..> 2025-05-01 17:50 5.4K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 5.4K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 5.5K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 5.5K
novartis-400x108.jpg 2020-03-11 11:59 5.5K
wsi-imageoptim-novar..> 2020-03-11 12:00 5.5K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 5.6K
RETHINKING_MS_Europe..> 2025-05-01 11:54 5.6K
RETHINKING_MS_Europe..> 2025-05-01 11:54 5.6K
novartis-300x214.jpg 2020-03-11 11:59 5.6K
wsi-imageoptim-novar..> 2020-03-11 12:00 5.6K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 5.6K
Methodology_NEW_V5_E..> 2025-05-01 11:54 5.7K
merck-300x214.jpg 2025-05-01 11:54 5.7K
wsi-imageoptim-merck..> 2025-05-01 11:54 5.7K
PolicyAssessmentTool..> 2025-05-01 11:54 5.8K
PolicyAssessmentTool..> 2025-05-01 11:54 5.8K
EBC-Newsletter-Novem..> 2020-03-11 11:59 5.8K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 5.9K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 5.9K
merck-320x202.jpg 2025-05-01 11:54 5.9K
wsi-imageoptim-merck..> 2025-05-01 11:54 5.9K
EBC-Newsletter-Novem..> 2019-12-17 10:44 6.0K
MS-in-times-of-COVID..> 2025-05-01 17:33 6.0K
novartis-320x202.jpg 2025-05-01 11:54 6.0K
wsi-imageoptim-novar..> 2025-05-01 11:54 6.0K
banner_partners-600x..> 2025-05-01 11:53 6.0K
wsi-imageoptim-banne..> 2025-05-01 11:54 6.0K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 6.1K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 6.1K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 6.3K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 6.3K
RETHINKING_MS_Europe..> 2025-05-01 11:54 6.3K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 6.3K
merck-400x190.jpg 2025-05-01 11:54 6.4K
wsi-imageoptim-merck..> 2025-05-01 11:54 6.4K
PolicyAssessmentTool..> 2025-05-01 11:54 6.5K
PolicyAssessmentTool..> 2025-05-01 11:54 6.5K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 6.5K
RETHINKING_MS_Europe..> 2025-05-01 11:54 6.5K
banner_partners-460x..> 2025-05-01 11:53 6.5K
wsi-imageoptim-banne..> 2025-05-01 11:54 6.5K
Design-sans-titre-37..> 2025-05-02 00:03 6.6K
Methodology_NEW_V5_E..> 2020-03-11 11:59 6.6K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 6.7K
banner_partners-540x..> 2025-05-01 11:53 6.7K
wsi-imageoptim-banne..> 2025-05-01 11:54 6.7K
PolicyAssessmentTool..> 2025-05-01 11:54 6.7K
PolicyAssessmentTool..> 2025-05-01 11:54 6.7K
Design-sans-titre-37..> 2025-05-02 00:03 6.9K
MS-in-times-of-COVID..> 2025-05-01 17:33 7.1K
biogen-540x272.jpg 2025-05-01 11:53 7.2K
wsi-imageoptim-bioge..> 2025-05-01 11:54 7.2K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 7.3K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 7.3K
MS-in-times-of-COVID..> 2025-05-01 17:50 7.7K
biogen-600x286.jpg 2025-05-01 11:53 7.9K
wsi-imageoptim-bioge..> 2025-05-01 11:54 7.9K
RETHINKING_MS_Spain_..> 2020-03-11 12:00 7.9K
PolicyAssessmentTool..> 2020-03-11 11:59 8.0K
PolicyAssessmentTool..> 2020-03-11 11:59 8.0K
MS-in-times-of-COVID..> 2025-05-01 17:50 8.0K
biogen-460x295.jpg 2025-05-01 11:53 8.0K
wsi-imageoptim-bioge..> 2025-05-01 11:54 8.0K
RETHINKING_MS_in_Ita..> 2020-03-11 12:00 8.1K
founders-600x98.jpg 2025-05-01 11:54 8.2K
wsi-imageoptim-found..> 2025-05-01 11:54 8.2K
Design-sans-titre-37..> 2025-05-02 00:03 8.2K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 8.3K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 8.3K
Virtual-exhibition-f..> 2025-05-01 17:50 8.4K
RETHINKING_MS_Europe..> 2025-05-01 11:54 8.5K
RETHINKING_MS_Europe..> 2025-05-01 11:54 8.5K
wsi-imageoptim-bioge..> 2019-12-22 15:46 8.5K
wsi-imageoptim-banne..> 2019-12-23 13:56 8.5K
banner_partners-768x..> 2025-05-01 11:53 8.5K
wsi-imageoptim-banne..> 2025-05-01 11:54 8.5K
ROMANIA_DEF_EBC_pp_0..> 2020-03-11 12:00 8.5K
ROMANIA_DEF_EBC_pp_0..> 2020-03-11 12:00 8.5K
banner_partners-669x..> 2025-05-01 11:53 8.6K
wsi-imageoptim-banne..> 2025-05-01 11:54 8.6K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 8.6K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 8.6K
merck-460x295.jpg 2025-05-01 11:54 8.6K
wsi-imageoptim-merck..> 2025-05-01 11:54 8.6K
MS-in-times-of-COVID..> 2025-05-01 17:50 8.7K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 8.7K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 8.7K
MS-in-times-of-COVID..> 2025-05-01 17:33 8.8K
RETHINKING_MS_Europe..> 2020-03-11 11:59 8.8K
celgene-300x214.jpg 2025-05-01 11:53 8.8K
wsi-imageoptim-celge..> 2025-05-01 11:54 8.8K
biogen-669x272.jpg 2025-05-01 11:53 8.8K
wsi-imageoptim-bioge..> 2025-05-01 11:54 8.8K
Methodology_NEW_V5_E..> 2025-05-01 11:54 8.8K
RETHINKING_MS_Denmar..> 2020-03-11 11:59 8.8K
EBC-Newsletter-Novem..> 2025-05-01 11:54 8.9K
Design-sans-titre-37..> 2025-05-02 00:03 8.9K
banner_partners-800x..> 2025-05-01 11:53 8.9K
wsi-imageoptim-banne..> 2025-05-01 11:54 8.9K
founders-460x160.jpg 2025-05-01 11:54 8.9K
wsi-imageoptim-found..> 2025-05-01 11:54 8.9K
MS-in-times-of-COVID..> 2025-05-01 17:33 9.0K
MS-in-times-of-COVID..> 2025-05-01 17:50 9.0K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 9.1K
celgene-300x251.jpg 2025-05-01 11:53 9.1K
wsi-imageoptim-celge..> 2025-05-01 11:54 9.1K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 9.2K
novartis-600x162.jpg 2025-05-01 11:54 9.2K
wsi-imageoptim-novar..> 2025-05-01 11:54 9.2K
celgene-320x202.jpg 2025-05-01 11:53 9.2K
wsi-imageoptim-celge..> 2025-05-01 11:54 9.2K
MS-in-times-of-COVID..> 2025-05-01 17:50 9.2K
MS-in-times-of-COVID..> 2025-05-01 17:50 9.4K
EBC-Newsletter-Novem..> 2025-05-01 11:54 9.4K
novartis-460x284.jpg 2025-05-01 11:54 9.4K
wsi-imageoptim-novar..> 2025-05-01 11:54 9.4K
merck-540x272.jpg 2025-05-01 11:54 9.6K
wsi-imageoptim-merck..> 2025-05-01 11:54 9.6K
RETHINKING_MS_Europe..> 2025-05-01 11:54 10K
Methodology_NEW_V5_E..> 2025-05-01 11:54 10K
merck-600x286.jpg 2025-05-01 11:54 10K
wsi-imageoptim-merck..> 2025-05-01 11:54 10K
novartis-540x272.jpg 2025-05-01 11:54 10K
wsi-imageoptim-novar..> 2025-05-01 11:54 10K
banner_partners-700x..> 2025-05-01 11:53 10K
wsi-imageoptim-banne..> 2025-05-01 11:54 10K
PolicyAssessmentTool..> 2025-05-01 11:54 10K
PolicyAssessmentTool..> 2025-05-01 11:54 10K
EBC-Newsletter-Novem..> 2025-05-01 11:54 10K
EBC-Newsletter-Novem..> 2025-05-01 11:54 10K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 11K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 11K
biogen-768x366.jpg 2025-05-01 11:53 11K
wsi-imageoptim-bioge..> 2025-05-01 11:54 11K
Virtual-exhibition-f..> 2025-05-01 17:50 11K
Virtual-exhibition-f..> 2025-05-01 17:50 11K
wsi-imageoptim-merck..> 2019-12-22 15:46 11K
founders-540x160.jpg 2025-05-01 11:54 11K
wsi-imageoptim-found..> 2025-05-01 11:54 11K
Design-sans-titre-37..> 2025-05-02 00:03 11K
founders-768x125.jpg 2025-05-01 11:54 11K
wsi-imageoptim-found..> 2025-05-01 11:54 11K
biogen-800x381.jpg 2025-05-01 11:53 11K
wsi-imageoptim-bioge..> 2025-05-01 11:54 11K
MS-in-times-of-COVID..> 2025-05-01 17:50 11K
merck-669x272.jpg 2025-05-01 11:54 11K
wsi-imageoptim-merck..> 2025-05-01 11:54 11K
MS-in-times-of-COVID..> 2025-05-01 17:50 12K
novartis-669x272.jpg 2025-05-01 11:54 12K
wsi-imageoptim-novar..> 2025-05-01 11:54 12K
wsi-imageoptim-novar..> 2019-12-22 15:46 12K
EBC-Newsletter-Novem..> 2020-03-11 11:59 12K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 12K
banner_partners-1024..> 2025-05-01 11:53 12K
wsi-imageoptim-banne..> 2025-05-01 11:54 12K
novartis-700x284.jpg 2025-05-01 11:54 12K
wsi-imageoptim-novar..> 2025-05-01 11:54 12K
founders-800x131.jpg 2025-05-01 11:54 12K
wsi-imageoptim-found..> 2025-05-01 11:54 12K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 13K
founders-669x160.jpg 2025-05-01 11:54 13K
wsi-imageoptim-found..> 2025-05-01 11:54 13K
novartis-800x216.jpg 2025-05-01 11:54 13K
wsi-imageoptim-novar..> 2025-05-01 11:54 13K
Virtual-exhibition-f..> 2025-05-01 17:50 13K
biogen-700x441.jpg 2025-05-01 11:53 13K
wsi-imageoptim-bioge..> 2025-05-01 11:54 13K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 13K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 13K
celgene-400x335.jpg 2025-05-01 11:53 13K
wsi-imageoptim-celge..> 2025-05-01 11:54 13K
novartis-768x208.jpg 2025-05-01 11:54 13K
wsi-imageoptim-novar..> 2025-05-01 11:54 13K
merck-768x366.jpg 2025-05-01 11:54 13K
wsi-imageoptim-merck..> 2025-05-01 11:54 13K
biogen-940x400.jpg 2025-05-01 11:53 13K
wsi-imageoptim-bioge..> 2025-05-01 11:54 13K
banner_partners-940x..> 2025-05-01 11:53 13K
wsi-imageoptim-banne..> 2025-05-01 11:54 13K
PolicyAssessmentTool..> 2025-05-01 11:54 13K
PolicyAssessmentTool..> 2025-05-01 11:54 13K
founders-700x160.jpg 2025-05-01 11:54 13K
wsi-imageoptim-found..> 2025-05-01 11:54 13K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 14K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 14K
merck-700x441.jpg 2025-05-01 11:54 14K
wsi-imageoptim-merck..> 2025-05-01 11:54 14K
RETHINKING_MS_Europe..> 2025-05-01 11:54 14K
merck-800x381.jpg 2025-05-01 11:54 14K
wsi-imageoptim-merck..> 2025-05-01 11:54 14K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 14K
celgene-460x295.jpg 2025-05-01 11:53 15K
wsi-imageoptim-celge..> 2025-05-01 11:54 15K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 15K
banner_partners-1200..> 2025-05-01 11:53 15K
wsi-imageoptim-banne..> 2025-05-01 11:54 15K
MS-in-times-of-COVID..> 2025-05-01 17:50 15K
RETHINKING_MS_Europe..> 2025-05-01 11:54 15K
biogen-1024x488.jpg 2025-05-01 11:53 15K
wsi-imageoptim-bioge..> 2025-05-01 11:54 15K
RETHINKING_MS_Europe..> 2025-05-01 11:54 15K
MS-in-times-of-COVID..> 2025-05-01 17:50 16K
Design-sans-titre-37..> 2025-05-02 00:03 16K
MS-in-times-of-COVID..> 2025-05-01 17:50 16K
celgene-540x272.jpg 2025-05-01 11:53 17K
wsi-imageoptim-celge..> 2025-05-01 11:54 17K
merck-940x400.jpg 2025-05-01 11:54 17K
wsi-imageoptim-merck..> 2025-05-01 11:54 17K
MS-in-times-of-COVID..> 2025-05-01 17:50 17K
founders-940x160.jpg 2025-05-01 11:54 17K
wsi-imageoptim-found..> 2025-05-01 11:54 17K
novartis-940x284.jpg 2025-05-01 11:54 17K
wsi-imageoptim-novar..> 2025-05-01 11:54 17K
Design-sans-titre-37..> 2025-05-02 00:03 17K
wsi-imageoptim-found..> 2019-12-22 16:04 17K
Methodology_NEW_V5_E..> 2025-05-01 11:54 18K
founders.jpg 2025-05-01 11:54 18K
wsi-imageoptim-found..> 2025-05-01 11:54 18K
novartis-1024x277.jpg 2025-05-01 11:54 18K
wsi-imageoptim-novar..> 2025-05-01 11:54 18K
biogen.jpg 2025-05-01 11:53 18K
wsi-imageoptim-bioge..> 2025-05-01 11:54 18K
merck-1024x488.jpg 2025-05-01 11:54 19K
wsi-imageoptim-merck..> 2025-05-01 11:54 19K
Virtual-exhibition-f..> 2025-05-01 17:50 19K
EBC-Newsletter-Novem..> 2025-05-01 11:54 19K
wsi-imageoptim-celge..> 2019-12-22 15:46 19K
MS-in-times-of-COVID..> 2025-05-01 17:50 20K
celgene-669x272.jpg 2025-05-01 11:53 20K
wsi-imageoptim-celge..> 2025-05-01 11:54 20K
MS-in-times-of-COVID..> 2025-05-01 17:50 20K
Virtual-exhibition-f..> 2025-05-01 17:50 21K
novartis.jpg 2025-05-01 11:54 21K
wsi-imageoptim-novar..> 2025-05-01 11:54 21K
Design-sans-titre-37..> 2025-05-02 00:03 21K
MS-in-times-of-COVID..> 2025-05-01 17:50 21K
MS-in-times-of-COVID..> 2025-05-01 17:50 21K
banner_partners-1536..> 2025-05-01 11:53 22K
wsi-imageoptim-banne..> 2025-05-01 11:54 22K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 22K
Design-sans-titre-37..> 2025-05-02 00:03 22K
celgene-600x502.jpg 2025-05-01 11:53 22K
wsi-imageoptim-celge..> 2025-05-01 11:54 22K
EBC-Newsletter-Novem..> 2025-05-01 11:54 22K
merck.jpg 2025-05-01 11:54 23K
wsi-imageoptim-merck..> 2025-05-01 11:54 23K
Methodology_NEW_V5_E..> 2025-05-01 11:54 23K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 23K
PolicyAssessmentTool..> 2025-05-01 11:54 24K
PolicyAssessmentTool..> 2025-05-01 11:54 24K
Virtual-exhibition-f..> 2025-05-01 17:50 24K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 24K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 24K
Methodology_NEW_V5_E..> 2025-05-01 11:54 24K
MS-in-times-of-COVID..> 2025-05-01 17:50 25K
Virtual-exhibition-f..> 2025-05-01 17:50 25K
celgene-700x441.jpg 2025-05-01 11:53 26K
wsi-imageoptim-celge..> 2025-05-01 11:54 26K
Methodology_NEW_V5_E..> 2025-05-01 11:54 26K
Methodology_NEW_V5_E..> 2020-03-11 11:59 26K
MS-in-times-of-COVID..> 2025-05-01 17:50 26K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 26K
MS-in-times-of-COVID..> 2025-05-01 17:50 27K
MS-in-times-of-COVID..> 2025-05-01 17:50 27K
RETHINKING_MS_Europe..> 2025-05-01 11:54 27K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 28K
MS-in-times-of-COVID..> 2025-05-01 17:50 28K
MS-in-times-of-COVID..> 2025-05-01 17:50 29K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 29K
EBC-Newsletter-Novem..> 2025-05-01 11:54 29K
EBC-Newsletter-Novem..> 2025-05-01 11:54 29K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 30K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 31K
PolicyAssessmentTool..> 2025-05-01 11:54 31K
PolicyAssessmentTool..> 2025-05-01 11:54 31K
celgene-768x643.jpg 2025-05-01 11:53 31K
wsi-imageoptim-celge..> 2025-05-01 11:54 31K
banner_partners-2048..> 2025-05-01 11:53 31K
wsi-imageoptim-banne..> 2025-05-01 11:54 31K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 31K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 31K
RETHINKING_MS_Spain_..> 2020-03-11 12:00 31K
MS-in-times-of-COVID..> 2025-05-01 17:50 32K
celgene-940x400.jpg 2025-05-01 11:53 32K
wsi-imageoptim-celge..> 2025-05-01 11:54 32K
celgene-800x670.jpg 2025-05-01 11:53 32K
wsi-imageoptim-celge..> 2025-05-01 11:54 32K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 32K
Design-sans-titre-37..> 2025-05-02 00:03 32K
RETHINKING_MS_in_Ita..> 2020-03-11 12:00 32K
MS-in-times-of-COVID..> 2025-05-01 17:50 32K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 32K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 32K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 32K
Design-sans-titre-37..> 2025-05-02 00:03 33K
PolicyAssessmentTool..> 2025-05-01 11:54 33K
PolicyAssessmentTool..> 2025-05-01 11:54 33K
PolicyAssessmentTool..> 2020-03-11 11:59 33K
PolicyAssessmentTool..> 2020-03-11 11:59 33K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 34K
PolicyAssessmentTool..> 2025-05-01 11:54 34K
PolicyAssessmentTool..> 2025-05-01 11:54 34K
Design-sans-titre-37..> 2025-05-02 00:03 34K
ROMANIA_DEF_EBC_pp_0..> 2020-03-11 12:00 34K
ROMANIA_DEF_EBC_pp_0..> 2020-03-11 12:00 34K
Virtual-exhibition-f..> 2025-05-01 17:50 35K
RETHINKING_MS_Europe..> 2025-05-01 11:54 35K
Virtual-exhibition-f..> 2025-05-01 17:50 35K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 35K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 35K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 36K
Virtual-exhibition-f..> 2025-05-01 17:50 37K
RETHINKING_MS_Denmar..> 2020-03-11 11:59 37K
RETHINKING_MS_Europe..> 2025-05-01 11:54 37K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 38K
RETHINKING_MS_Europe..> 2020-03-11 12:00 38K
Design-sans-titre-37..> 2025-05-02 00:03 39K
MS-in-times-of-COVID..> 2025-05-01 17:50 39K
MS-in-times-of-COVID..> 2025-05-01 17:50 39K
RETHINKING_MS_Europe..> 2025-05-01 11:54 40K
EBC-Newsletter-Novem..> 2025-05-01 11:54 42K
Methodology_NEW_V5_E..> 2025-05-01 11:54 42K
banner_partners-scal..> 2025-05-01 11:53 42K
wsi-imageoptim-banne..> 2025-05-01 11:54 42K
Virtual-exhibition-f..> 2025-05-01 17:50 44K
MS-in-times-of-COVID..> 2025-05-01 17:50 45K
celgene-1024x857.jpg 2025-05-01 11:53 46K
wsi-imageoptim-celge..> 2025-05-01 11:54 46K
Methodology_NEW_V5_E..> 2020-03-11 11:59 46K
MS-in-times-of-COVID..> 2025-05-01 17:50 47K
RETHINKING_MS_Spain_..> 2025-05-01 11:54 47K
RETHINKING_MS_in_Ita..> 2025-05-01 11:54 47K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 49K
ROMANIA_DEF_EBC_pp_0..> 2025-05-01 11:54 49K
RETHINKING_MS_Spain_..> 2020-03-11 12:00 50K
RETHINKING_MS_in_Ita..> 2020-03-11 12:00 51K
ROMANIA_DEF_EBC_pp_0..> 2020-03-11 12:00 52K
ROMANIA_DEF_EBC_pp_0..> 2020-03-11 12:00 52K
PolicyAssessmentTool..> 2025-05-01 11:54 54K
PolicyAssessmentTool..> 2025-05-01 11:54 54K
EBC-Newsletter-Novem..> 2025-05-01 11:54 54K
Design-sans-titre-37..> 2025-05-02 00:03 55K
RETHINKING_MS_Denmar..> 2025-05-01 11:54 55K
PolicyAssessmentTool..> 2020-03-11 11:59 57K
PolicyAssessmentTool..> 2020-03-11 11:59 57K
EBC-Newsletter-Novem..> 2025-05-01 11:54 57K
celgene.jpg 2025-05-01 11:53 57K
wsi-imageoptim-celge..> 2025-05-01 11:54 57K
RETHINKING_MS_Denmar..> 2020-03-11 11:59 59K
Virtual-exhibition-f..> 2025-05-01 17:50 60K
RETHINKING_MS_Europe..> 2025-05-01 11:54 60K
RETHINKING_MS_Europe..> 2020-03-11 11:59 64K
MS-in-times-of-COVID..> 2025-05-01 17:50 64K
Design-sans-titre-37..> 2025-05-02 00:03 71K
EBC-Newsletter-Novem..> 2025-05-01 11:54 80K
EBC-Newsletter-Novem..> 2025-05-01 11:54 87K
EBC-Newsletter-Novem..> 2020-03-11 11:59 87K
MS-in-times-of-COVID..> 2025-05-01 17:50 91K
banner_partners.jpg 2025-05-01 11:53 91K
wsi-imageoptim-banne..> 2025-05-01 11:54 91K
EBC-Newsletter-Novem..> 2025-05-01 11:54 94K
MS-in-times-of-COVID..> 2025-05-01 17:50 118K
EBC-Newsletter-Novem..> 2025-05-01 11:54 171K
EBC-Newsletter-Novem..> 2020-03-11 11:59 181K
![[ ]](/__ovh_icons/layout.gif)
Methodology_NEW_V5_E..> 2019-12-02 22:06 253K
PolicyAssessmentTool..> 2019-12-04 00:19 414K
PolicyAssessmentTool..> 2019-12-02 22:06 414K
EBC-Newsletter-Novem..> 2019-12-17 10:44 663K
RETHINKING_MS_Spain_..> 2019-12-02 22:06 3.6M
RETHINKING_MS_Denmar..> 2019-12-02 22:06 3.7M
RETHINKING_MS_in_Ita..> 2019-12-02 22:06 3.7M
ROMANIA_DEF_EBC_pp_0..> 2019-12-02 22:07 4.0M
ROMANIA_DEF_EBC_pp_0..> 2019-12-04 00:19 4.0M
RETHINKING_MS_Europe..> 2019-12-02 22:06 4.1M